Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
01/2011
01/26/2011CN101955498A Novel side chain of 25-hydroxyitamin D2 series medicines and preparation method thereof
01/26/2011CN101955497A Process technology for producing high content phosethyl-Al original drug
01/26/2011CN101955437A Glyphosate and glycine co-production technology by utilizing IDA method
01/26/2011CN101955431A Recovery process of catalyst triethylamine in process of synthesizing glyphosate
01/26/2011CN101955413A Method for separating acidic dichloroethane mixture
01/26/2011CN101463044B Mechanochemical synthesis of ammonium glyphosate preparation
01/26/2011CN101210030B Method for preparing oligomerization phosphoric acid ester or oligomerization phosphorous acid ester
01/25/2011US7875739 Detoxification of hazardous materials; rapid lanthanum ion catalyzed alcoholysis
01/25/2011US7875727 Benzimidazole vascular damaging agents
01/25/2011CA2601025C Novel derivatives of phosphinic amino acids, preparation method thereof and pharmaceutical compositions containing same
01/25/2011CA2494619C Collector for sulfide ores
01/25/2011CA2470888C Trimerisation and oligomerisation of olefins using a chromium based catalyst
01/25/2011CA2405853C Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts
01/25/2011CA2385322C A substantially cell membrane impermeable compound and use thereof
01/25/2011CA2339834C Water soluble prodrugs of hindered alcohols or phenols
01/25/2011CA2337857C Calcium (3s) tetrahydro-3-furanyl(1s,2r)-3-[[(4-aminophenyl) sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate
01/20/2011WO2011009075A2 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
01/20/2011WO2011008453A2 N-phosphonomethylglycine guanidine derivative salts
01/20/2011WO2010129918A8 Triptolide prodrugs
01/20/2011WO2010123599A3 Anti-bacterial compositions and methods including targeting virulence factors of staphylococcus aureus
01/20/2011WO2010120370A3 Gamma-amino-butyric acid derivatives as gabab receptor ligands
01/20/2011WO2009093258A3 A new and improved process for the preparation of ibandronate sodium monohydrate
01/20/2011US20110016581 Delta-8 desaturases and their use in making polyunsaturated fatty acids
01/20/2011US20110015440 Phosphine compound, process for producing the same, and peroxide scavenger using the same
01/20/2011US20110015396 Tunable phenylacetylene hosts
01/20/2011US20110015384 Sulfurization agent and its use
01/20/2011US20110015156 Heterocyclic compounds for the treatment of neurological and psychological disorders
01/20/2011US20110015155 Deuterated 2, 4-Pyrimidinediamine Compounds and Prodrugs Thereof and Their Uses
01/20/2011US20110015061 Tetramerization
01/20/2011DE102009000881A1 Mischungen aus Metallhydriden und lonischen Flüssigkeiten und Verwendungen solcher Mischungen Mixtures of metal hydrides and ionic liquids and uses of such mixtures
01/20/2011CA2768368A1 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
01/20/2011CA2766374A1 N-phosphonomethylglycine guanidine derivative salts
01/19/2011EP2275522A2 Enzymatic oil-degumming method
01/19/2011EP2275401A1 Crystalline 1-{[(a-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid
01/19/2011EP2275398A1 Application of the iridium complex in asymmetric catalytic hydrogenation for unsaturated carboxylic acid
01/19/2011EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds
01/19/2011EP2274311A2 Compounds and methods for the treatment of viral infection
01/19/2011EP2274291A2 Reactive ionic liquids
01/19/2011EP2274277A2 A process for the production of nitrogen or phosphorus containing compounds from synthesis gas
01/19/2011EP2273980A2 Pharmaceutical composition with bisphosphonate
01/19/2011EP1713489B1 Crystalline form of ibandronate sodium and processes for preparation thereof
01/19/2011EP1644389B1 Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
01/19/2011CN201711015U Dismantle free type filter
01/19/2011CN1997616B Minimization of ligand degradation products, of reversion of same to useful phosphine ligands
01/19/2011CN1775786B Method for separating and concentrating glyphosate stock solution
01/19/2011CN101952299A Production of lithium diphenylphosphide
01/19/2011CN101952298A Ligands for transition-metal-catalyzed cross-couplings, and methods of use thereof
01/19/2011CN101949096A Bridge-type waterborne polyurethane flame retardant finishing agent and preparation method thereof
01/19/2011CN101948581A Intumescent flame retardant polyethylene containing organosilicon compound
01/19/2011CN101948487A Method for synthesizing dithio dineopentyl phosphate fire retardant
01/19/2011CN101948486A Synthesis method of 2,2'-methylene-bis(4,6-dibert-butylphenol) phosphate
01/19/2011CN101948485A Alpha crystal form of tenofovir disoproxil fumarate, and preparation method and application thereof
01/19/2011CN101948484A Method for preparing travoprost intermediate
01/19/2011CN101948483A Method for preparing calcium soap by utilizing quick lime and method for processing produced emulsified compound
01/19/2011CN101948482A Process for producing glyphosate ammonium dry powder
01/19/2011CN101948434A Chiral tyrosine radical ionic liquid
01/19/2011CN101947434A Lamellar zirconium glyphosate using as lead-ion absorbing material
01/19/2011CN101601407B Method for producing glyphosate sylvine aqua with glyphosate mother liquor
01/19/2011CN101423530B Soya bean lecithin hydrogenization method using supercritical CO2 as dissolving agent
01/19/2011CN101353358B Method for preparing N-(phosphonomethyl) glycine with improved reaction system
01/19/2011CN101307073B Method for decreasing N-phosphonomethyliminodiacetic acid waste water and reducing salt content of the waste water
01/18/2011US7872157 Phosphonite containing catalysts for hydroformylation processes
01/18/2011US7872156 show ligand acceleration effect for simple alkenes, i.e., the hydroformylation activity increases as the concentration of ligand increases, and are capable of producing linear or branched aldehydes ; catalyst stability; reacting propylene, h2 and co2 to make iso-butyraldehyde
01/18/2011US7872144 Process for producing biphosphonic acids and forms thereof
01/18/2011US7872134 2-{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N-bis(2-chloroethyl)phosphorodiamidates
01/18/2011US7872044 Inhibitors of chymase
01/18/2011US7871992 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP)
01/18/2011US7871991 Phosphonate analogs of HIV inhibitor compounds
01/18/2011CA2408008C Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
01/18/2011CA2333987C Compounds and methods for detecting biomolecules
01/13/2011WO2011005653A1 Solution based precursors
01/13/2011WO2011004705A1 Polyfluoroalkylphosphonic acid esters and processes for production of same
01/13/2011WO2011004604A1 Diphenyl sulfide derivatives and medicines containing same as active ingredient
01/13/2011WO2010118309A3 Inhibitors of stat3 and uses thereof
01/13/2011US20110009657 Method for the Synthesis of a Rare-Earth Organophosphate and Use Thereof for Preparing a Preformed Catalytic System
01/13/2011US20110009629 Preparation of morpholine derivatives
01/13/2011US20110009558 Room-temperature vulcanisable organopolysiloxane compound to give an elastomer and novel organopolysiloxane polycondensation catalysts
01/13/2011US20110009539 Flameproof pmma molding compound
01/13/2011US20110009369 Anti-influenza compounds
01/13/2011US20110009368 Solid forms of tenofovir disoproxil
01/13/2011US20110009367 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
01/13/2011US20110009356 Novel phosphorus-containing prodrugs
01/13/2011US20110009355 Azapeptide Derivatives
01/13/2011US20110008634 Rust inhibitor and surface treatment metal material
01/13/2011US20110008461 Inhibitor scaffold for the inhibition of the enzyme phosphoenolpyruvate carboxykinase
01/13/2011US20110008415 Novel lipophilic compositions and uses thereof
01/13/2011US20110008373 Prodrugs of cc-1065 analogs
01/13/2011US20110008288 Hepatitis c virus inhibitors
01/13/2011CA2766277A1 Polyfluoroalkylphosphonic acid ester and process for producing the same
01/13/2011CA2764126A1 Diphenyl sulfide derivatives and medicines containing same as active ingredient
01/12/2011EP2272853A1 Spiro phosphorus-oxazoline, synthesis and use thereof
01/12/2011EP2272852A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex
01/12/2011EP2272838A1 Fostriecin derivatives and the pharmaceutical uses thereof
01/12/2011EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds
01/12/2011EP2271651A1 Isothermal process for phosphoromonochloridite synthesis
01/12/2011EP2271623A2 Perpropionic acid composition that is stable in a basic medium
01/12/2011CN101945883A Diaryl alkylphosphonates and methods for preparing same
01/12/2011CN101945874A 3-substituted-4-0x0-3, 4-dihydro-imidazo- [5, 1-d] [1,2,3,5] -tetrazine-8-carboxylic acid amides as anticancer agents
01/12/2011CN101945580A Azolylmethyloxiranes, use thereof and agents containing the same
01/12/2011CN101942297A Fatty acid amide potassium phosphate betaine surfactant for tertiary oil recovery, and preparation method and application thereof
1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 554